Background/Objectives: Pneumonia remains a leading cause of emergency department visits worldwide, requiring rapid and objective risk stratification. While traditional scoring systems like CURB-65 and the Pneumonia Severity Index (PSI) are well-established, there is a constant need for dynamic biomarkers reflecting the underlying pathophysiology. This study aims to investigate the prognostic value of the hemoglobin-to-lactate ratio (HLR) in predicting mortality among pneumonia patients. Methods: This retrospective cohort study included 183 adult patients diagnosed with pneumonia at a tertiary training and research hospital between October 2024 and November 2025. Demographic data, clinical findings, laboratory parameters, and prognostic scores (CURB-65, PSI) were recorded. The impact of HLR on mortality was evaluated using univariate and multivariate logistic regression, while its predictive performance was assessed via Receiver Operating Characteristic (ROC) analysis and compared with clinical scores using DeLong’s method. Results: The overall mortality rate was 32.8%. HLR values were significantly lower in the exitus group compared to survivors (4.68 vs. 6.92, p < 0.001). Multivariate analysis revealed that an HLR ≤ 5.65 was an independent predictor of mortality, associated with a 10-fold increase in risk (OR: 10.0; 95% CI: 4.15–24.19; p < 0.001). HLR demonstrated high predictive power (AUC = 0.802), comparable to CURB-65 (AUC = 0.807) and PSI (AUC = 0.829). Notably, the combined HLR + CURB-65 model provided the highest diagnostic accuracy (AUC = 0.857, p = 0.037). Conclusions: HLR is a low-cost and easily accessible biomarker for predicting mortality in pneumonia. It effectively reflects the physiological balance between tissue oxygenation and metabolic failure. Integrating HLR into clinical practice, particularly when combined with traditional scores, can enhance risk (decision of discharge, admission unit ward, ICU, evaluation of prognosis) in the emergency department.
Ikiz et al. (Fri,) studied this question.